Reduced placental prolyl hydroxylase 3 mRNA expression in pregnancies affected by fetal growth restriction.
Gourvas
V
V
Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece.
Sifakis
S
S
Dalpa
E
E
Soulitzis
N
N
Koukoura
O
O
Spandidos
D A
DA
D000328:Adult; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator / Q000378:metabolism; D051792:Basic Helix-Loop-Helix Proteins / Q000378:metabolism; D001724:Birth Weight; D016022:Case-Control Studies; D018076:DNA, Complementary / Q000378:metabolism; D005260:Female; D005317:Fetal Growth Retardation / Q000201:enzymology*; D005865:Gestational Age; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D008297:Male; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D011393:Procollagen-Proline Dioxygenase / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism*; D000099162:Endothelial PAS Domain-Containing Protein 1
D051784:Aryl Hydrocarbon Receptor Nuclear Translocator; D051792:Basic Helix-Loop-Helix Proteins; D018076:DNA, Complementary; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D011393:Procollagen-Proline Dioxygenase; D012333:RNA, Messenger; D000099162:Endothelial PAS Domain-Containing Protein 1; C497396:ARNT protein, human; C497442:HIF1A protein, human; C030606:proline, 2-oxoglutarate 3-dioxygenase